These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 9766719

  • 1. Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma.
    Rankin SC, Taylor H, Cook GJ, Mason R.
    Clin Radiol; 1998 Sep; 53(9):659-65. PubMed ID: 9766719
    [Abstract] [Full Text] [Related]

  • 2. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
    Katsoulis IE, Wong WL, Mattheou AK, Damani N, Chambers J, Livingstone JI.
    Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
    [Abstract] [Full Text] [Related]

  • 3. [Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].
    Kneist W, Schreckenberger M, Bartenstein P, Grünwald F, Oberholzer K, Junginger T.
    Chirurg; 2003 Oct; 74(10):922-30; discussion 929-30. PubMed ID: 14605734
    [Abstract] [Full Text] [Related]

  • 4. [Positron emission tomography for the preoperative staging of esophageal carcinoma].
    Junginger T, Kneist W, Schreckenberger M, Menzel C, Oberholzer K, Bartenstein P.
    Dtsch Med Wochenschr; 2002 Sep 20; 127(38):1935-41. PubMed ID: 12239652
    [Abstract] [Full Text] [Related]

  • 5. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
    Salahudeen HM, Balan A, Naik K, Mirsadraee S, Scarsbrook AF.
    Clin Radiol; 2008 Jul 20; 63(7):765-73. PubMed ID: 18555034
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
    Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K.
    Cancer; 2005 Jan 01; 103(1):148-56. PubMed ID: 15558794
    [Abstract] [Full Text] [Related]

  • 8. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.
    Meltzer CC, Luketich JD, Friedman D, Charron M, Strollo D, Meehan M, Urso GK, Dachille MA, Townsend DW.
    Clin Nucl Med; 2000 Nov 01; 25(11):882-7. PubMed ID: 11079584
    [Abstract] [Full Text] [Related]

  • 9. Dual-time point 18F-FDG PET/CT for the staging of oesophageal cancer: the best diagnostic performance by retention index for N-staging in non-calcified lymph nodes.
    Park S, Paeng JC, Kang CH, Cheon GJ, Kang KW, Chung JK, Lee DS.
    Eur J Nucl Med Mol Imaging; 2018 Jul 01; 45(8):1317-1328. PubMed ID: 29502309
    [Abstract] [Full Text] [Related]

  • 10. External ultrasonography of the neck does not add diagnostic value to integrated positron emission tomography-computed tomography (PET-CT) scanning in the diagnosis of cervical lymph node metastases in patients with esophageal carcinoma.
    Blom RL, Vliegen RF, Schreurs WM, Belgers HJ, Stohr I, Oostenbrug LE, Sosef MN.
    Dis Esophagus; 2012 Aug 01; 25(6):555-9. PubMed ID: 22150869
    [Abstract] [Full Text] [Related]

  • 11. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
    Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL.
    J Thorac Oncol; 2014 Aug 01; 9(8):1202-6. PubMed ID: 25157774
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma.
    Kato H, Miyazaki T, Nakajima M, Fukuchi M, Manda R, Kuwano H.
    Br J Surg; 2004 Aug 01; 91(8):1004-9. PubMed ID: 15286962
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metabolic information on staging FDG-PET-CT as a prognostic tool in the evaluation of 97 patients with gastric cancer.
    Coupe NA, Karikios D, Chong S, Yap J, Ng W, Merrett N, Lin M.
    Ann Nucl Med; 2014 Feb 01; 28(2):128-35. PubMed ID: 24297388
    [Abstract] [Full Text] [Related]

  • 18. Role of positron emission tomography in the (re-)staging of oesophageal cancer.
    Westerterp M, Van Westreenen HL, Sloof GW, Plukker JT, Van Lanschot JJ.
    Scand J Gastroenterol Suppl; 2006 Feb 01; (243):116-22. PubMed ID: 16782630
    [Abstract] [Full Text] [Related]

  • 19. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study.
    Yoon YC, Lee KS, Shim YM, Kim BT, Kim K, Kim TS.
    Radiology; 2003 Jun 01; 227(3):764-70. PubMed ID: 12773680
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma.
    McAteer D, Wallis F, Couper G, Norton M, Welch A, Bruce D, Park K, Nicolson M, Gilbert FJ, Sharp P.
    Br J Radiol; 1999 Jun 01; 72(858):525-9. PubMed ID: 10560332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.